Citadel Advisors’s NorthView Acquisition Corporation Rights NVACR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVACR
MP
PAMP
SCM
CAC
PC
PL
BFM
YCM
SCM
RCM
Citadel Advisors's NVACR Position: Q4 2022 in Review
Citadel Advisors sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2022, closing a stake of 10,043 shares — an estimated $1K sold.
Citadel Advisors first reported a position in NVACR in Q1 2022 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 34 funds tracked by Wall St. Rank hold NVACR as of Q4 2022.
- Citadel Advisors reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2022 after selling out during the quarter.
- Citadel Advisors sold 10,043 NorthView Acquisition Corporation Rights shares in Q4 2022, an estimated $1K.
- Citadel Advisors first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 2 quarters.
- Citadel Advisors's NorthView Acquisition Corporation Rights position peaked at $5K in Q1 2022.
- 34 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2022.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.